scholarly journals Predictors of Conversion and Outcomes for Patients Undergoing Minimally Invasive Hepatectomy: A Contemporary ASC NSQIP Analysis

HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S41
Author(s):  
C. Vining ◽  
K. Kuchta ◽  
D. Schuitevoerder ◽  
P. Paterakos ◽  
Y. Berger ◽  
...  
HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S8
Author(s):  
C. Vining ◽  
K. Kuchta ◽  
Y. Berger ◽  
P. Paterakos ◽  
D. Schuitevoerder ◽  
...  

HPB ◽  
2020 ◽  
Author(s):  
Diamantis I. Tsilimigras ◽  
J. Madison Hyer ◽  
Qinyu Chen ◽  
Adrian Diaz ◽  
Anghela Z. Paredes ◽  
...  

Author(s):  
Alexander M. Fagenson ◽  
Elizabeth M. Gleeson ◽  
Henry A. Pitt ◽  
Kwan N. Lau

2016 ◽  
Vol 150 (4) ◽  
pp. S1238
Author(s):  
Rebecca M. Dodson ◽  
Harveshp Mogal ◽  
Nora Fino ◽  
Clancy J. Clark ◽  
Perry Shen

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 430-430
Author(s):  
Jack P Silva ◽  
Nicholas G Berger ◽  
Susan Tsai ◽  
Kathleen K. Christians ◽  
Callisia Clarke ◽  
...  

430 Background: Surgical approach has been described as a factor influencing morbidity in patients undergoing hepatectomy. Minimally invasive surgery (MIS) converted to open has previously been included in an open hepatectomy cohort of the National Surgical Quality Improvement Program (NSQIP) dataset for analysis. This study sought to compare MIS conversion to open hepatectomy cases and analyze factors leading to conversion. Methods: The NSQIP data set was queried for patients undergoing hepatectomy for liver disease between January 1, 2014 and December 31, 2014. Cases were divided into three cohorts: completely MIS (laparoscopic or robotic), open, or planned MIS converted to open approach according to the dataset definitions. Demographic, clinical-pathologic, and perioperative variables were described and short-term postoperative outcomes were compared between groups. Results: A total of 2,884 patients were identified. Open approach was performed most commonly (80.96%, n = 2,335), followed by minimally invasive (15.05%, n = 434) and MIS converted to open (3.99%, n = 115). Patients undergoing conversion were more likely to have higher BMI, hypertension, and hepatocellular carcinoma. Conversion patients suffered from significantly higher morbidity (p < 0.001) compared to MIS, but had comparable outcomes to open procedures. Conclusions: MIS hepatectomy has been shown to have lower morbidity but similar mortality to open hepatectomy. Conversion procedures appear to have similar outcomes to open procedures, with greater morbidity compared to MIS. Differences in morbidity from previous studies may be partially attributed to the inclusion of conversions in the open hepatectomy cohort.


2020 ◽  
Vol 158 (6) ◽  
pp. S-1551
Author(s):  
Alexander M. Fagenson ◽  
Sunil S. Karhadkar ◽  
Antonio Di Carlo ◽  
Henry A. Pitt ◽  
Kwan N Lau

HPB ◽  
2017 ◽  
Vol 19 (11) ◽  
pp. 957-965 ◽  
Author(s):  
Zachary E. Stiles ◽  
Stephen W. Behrman ◽  
Evan S. Glazer ◽  
Jeremiah L. Deneve ◽  
Lei Dong ◽  
...  

HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S833-S834
Author(s):  
H. Lillemoe ◽  
B. Kim ◽  
R. Marcus ◽  
R. Day ◽  
T. Aloia

2019 ◽  
Vol 37 (1) ◽  
pp. 65-71 ◽  
Author(s):  
Charing Ching-Ning Chong ◽  
Kit-Fai Lee ◽  
Cheuk-Man Chu ◽  
Anthony Wing-Hung Chan ◽  
Simon Chun-Ho Yu ◽  
...  

Background: The advantages of radiofrequency ablation (RFA) over hepatectomy as a treatment for early-stage hepatocellular carcinoma (HCC) include reduced morbidity and more rapid recovery. Although minimally invasive surgery provides similar benefits, few studies have compared the long-term oncological outcomes of these techniques. This study aimed to compare the outcomes of minimally invasive hepatectomy (MIH) and RFA. Methods: Patients who underwent MIH or RFA for HCC between January 2005 and January 2015 were included in a propensity score matching analysis. Only patients who underwent minimally invasive procedures for small HCC were included. Baseline clinical and laboratory parameters were retrieved from the hospital database and analyzed. Results: Two hundred and twenty-five patients underwent MIH or RFA for HCC during the study period. Propensity score matching yielded 59 patient-pairs. The complication rates did not differ statistically between the 2 groups (p = 0.309). However, MIH provided significantly better overall (p = 0.005) and disease-free survival outcomes (p < 0.001) than RFA. Conclusions: Compared with RFA, MIH provided better long-term survival outcomes in patients with early-stage HCC, with no increase in the incidence of complications. When feasible, MIH should be considered a first-line treatment for this patient population.


Sign in / Sign up

Export Citation Format

Share Document